using a randomized prospective trial design , chemotherapy with 5-fluorouracil , vincristine , and mitomycin c ( fomi ) was compared with cyclophosphamide , doxorubicin , and cisplatin ( cap ) and with fomi alternating with cap ( fomi/cap ) in 452 eligible patients with metastatic large-cell undifferentiated and adenocarcinoma of the lung .
C0042679
vincristine
C0060627
fomi